These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6133652)

  • 1. Can beta blockers be safely used in patients with recent myocardial infarction who also have congestive heart failure?
    Julian DG
    Circulation; 1983 Jun; 67(6 Pt 2):I91. PubMed ID: 6133652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of beta-blockers in the pharmacologic treatment of congestive heart failure].
    Longo A
    Rev Port Cardiol; 1989; 8(7-8):563-8. PubMed ID: 2576636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of beta-blockers during and after myocardial infarction.
    Aronow WS
    Compr Ther; 1998; 24(6-7):327-31. PubMed ID: 9669097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis.
    TenBrook JA; Wolf MP; Hoffman SN; Rosenwasser LJ; Konstam MA; Salem DN; Wong JB
    J Allergy Clin Immunol; 2004 May; 113(5):977-82. PubMed ID: 15131583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing beta-blocker use after myocardial infarction.
    Howard PA; Ellerbeck EF
    Am Fam Physician; 2000 Oct; 62(8):1853-60, 1865-6. PubMed ID: 11057841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta-adrenergic receptor blockers in clinical practice].
    Czuriga I; Edes I
    Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blockers: a new therapy in congestive heart failure.
    Meghani SH; Becker D
    Am J Crit Care; 2001 Nov; 10(6):417-27; quiz 428-9. PubMed ID: 11688609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of inpatient initiation of beta-blockers.
    Ventura HO
    Am Heart J; 2004 Dec; 148(6):944-50. PubMed ID: 15632876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blockers in hypertensive and coronary heart disease.
    Goldstein S
    Arch Intern Med; 1996 Jun; 156(12):1267-76. PubMed ID: 8651834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of beta-blockers in acute myocardial infarct].
    Petrov K
    Vutr Boles; 1990; 29(3):20-6. PubMed ID: 1980963
    [No Abstract]   [Full Text] [Related]  

  • 12. Are we misunderstanding beta-blockers.
    Cruickshank JM
    Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of heart failure with beta-blockers?].
    Osterziel KJ; Dietz R
    Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blocker use in patients with congestive heart failure and concomitant obstructive airway disease: moving from myth to evidence-based practice.
    Ormiston TM; Salpeter SR
    Heart Fail Monit; 2003; 4(2):45-54. PubMed ID: 14724718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotection with beta-blockers: myths, facts and Pascal's wager.
    Messerli FH; Bangalore S; Yao SS; Steinberg JS
    J Intern Med; 2009 Sep; 266(3):232-41. PubMed ID: 19702791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-myocardial infarction beta-blocker therapy: the bradycardia conundrum. Rationale and design for the Pacemaker & beta-blocker therapy post-MI (PACE-MI) trial.
    Goldberger JJ; Bonow RO; Cuffe M; Dyer A; Greenland P; Rosenberg Y; O'Rourke R; Shah PK; Smith S
    Am Heart J; 2008 Mar; 155(3):455-64. PubMed ID: 18294477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure.
    Wada K; Fujimori A; Matsukawa U; Arai Y; Sudoh K; Yatsu T; Sasamata M; Miyata K
    Eur J Pharmacol; 2005 Jan; 507(1-3):145-51. PubMed ID: 15659304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy.
    O'Connor CM; Gottlieb S; Bourque JM; Krause-Steinrauf H; Anand I; Anderson JL; Plehn JF; Silver MA; White M; Carson P;
    Am J Cardiol; 2005 Mar; 95(5):558-64. PubMed ID: 15721091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure.
    Hognestad A; Dickstein K; Myhre E; Snapinn S; Kjekshus J;
    Am J Cardiol; 2004 Mar; 93(5):603-6. PubMed ID: 14996587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF.
    Jánosi A; Ghali JK; Herlitz J; Czuriga I; Klibaner M; Wikstrand J; Hjalmarson A;
    Am Heart J; 2003 Oct; 146(4):721-8. PubMed ID: 14564329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.